Table 1. Distribution of diagnostic tests and treatments received by diagnosed human CE cases in 2005 (13 cases) and for the period between 1991 and 2007 (154 cases) in the two major hospitals capturing all CE cases in Álava.
| Period | ||
| Type of diagnosis and treatment (%) | 2005 | 1991–2007 |
| Diagnosis | ||
| Clinicala | 7.7 | 10.5 |
| Serology | 23.1 | 15.7 |
| Chest X-ray | 15.4 | 5.2 |
| CT | 76.9 | 73.2 |
| Ultrasonography | 30.8 | 43.8 |
| MRI | 7.7 | 7.8 |
| No Data | 0.0 | 5.2 |
| Treatment | ||
| Chemotherapy | 15.4 | 11.8 |
| Surgery | 46.1 | 54.9 |
| Total exeresis | 23.1 | 20.2 |
| Partial exeresis | 7.7 | 28.1 |
| Not specified | 15.3 | 6.6 |
| None | 38.5 | 41.8 |
| No data | 0.0 | 0.6 |
| Post-treatment recidives b | 61.5 | 66.2 |
| Treatment of recidival c cases | Over 2 patients | Over 21 patients |
| Chemotherapy | 50.0 | 33.3 |
| Surgery | 0.0 | 57.1 |
| Combined | 0.0 | 4.8 |
| None | 50.0 | 4.8 |
| Follow up | ||
| Yes | 38.5 | 47.3 |
| Average (Months) | 13.5 | 37.2 |
| No | 61.5 | 46.7 |
| No data | 0.0 | 6.0 |
| Mortality due to CE | 7.7 | 3.9 |
| Length of hospital stay (Days) | 18.4 | 10.4 |
a
Diagnosis based on signs and symptoms of the disease.
b
Patients with recrudescent disease after surgical and/or chemotherapeutical treatment.
c
Treatment provided to those patients that experienced recrudescence of the disease after being chemotherapeutical- or surgically treated.